GO-ALIVE study by Prof ADeodhar & grp 🔘IV GOL was shown to be effective across all efficacy outcomes in AS pts w/ early & late dse 🔘⬆proportions of pts w/ early dse achieved BASDAI50 and ASDAS inactive dse Early dx and tx 👉better outcomes @RheumNow #ACR21 #ACRBest abs0912 https://t.co/jwvEn5LdDB